Background In asymptomatic patients with inflammatory bowel disease (IBD),“monitoring”
involves repeated testing aimed at early recognition of disease exacerbation. We aimed to …

Background & Aims An increasing number of physicians use repeated measurements of
stool calprotectin to monitor intestinal inflammation in patients with inflammatory bowel …

Abstract Background and Aims Conventional follow-up of teenagers with inflammatory
bowel diseases [IBD] is done during scheduled outpatient visits regardless of how well the …

Background We designed a telemonitoring strategy for teenagers with inflammatory bowel
disease to prevent an anticipated disease flare and avert unplanned office visits and day …

Objective Calgranulin-C (S100A12) is a new faecal marker of inflammation that is potentially
more specific for inflammatory bowel disease (IBD) than calprotectin, since it is only …

Objective To study the association between Dientamoebafragilis colonisation and faecal
calprotectin to see whether the parasite is a harmless commensal or a gut pathogen. Design …

In children with suspected inflammatory bowel disease, adding calprotectin stool testing to
the screening strategy has been recommended to distinguish organic from nonorganic …

Background To prevent clinical relapse in teenagers with inflammatory bowel disease (IBD)
there is a need to monitor disease activity continuously. Timely optimisation of medical …

Introduction The introduction of the faecal calprotectin (FC) test to screen children with
chronic gastrointestinal complaints has helped the clinician to decide whether or not to …

Introduction Children often present to primary care with functional abdominal pain (FAP) or
irritable bowel syndrome (IBS), and around half still have abdominal complaints 1 year later …